Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Beyond Retinal Safety: Rethinking the Benefit–Risk Profile of Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors in CKD Anaemia. Local targets link to admitted publications; unresolved targets remain external evidence.
Efficacy and Safety of Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors in Patients With Chronic Kidney Disease: Meta‐Analysis of Phase 3 Randomized Controlled Trials
10.1093/ckj/sfad143 · 2024 · External reference
Unresolved reference
External reference
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
10.1016/j.kint.2025.06.005 · 2026 · External reference
Network Meta‐Analysis of HIF‐Prolyl Hydroxylase Inhibitors for Anemia in Dialysis‐Dependent and Non‐Dialysis CKD: Effects on Hemoglobin, Iron Markers, and Adverse Clinical Outcomes
10.1186/s12882-025-04561-x · 2025 · External reference
Long Non‐Coding RNA NNT‐AS1 Links Inflammation, Tubular Injury, and Prognosis in Septic AKI
10.1111/nep.70142 · 2025 · External reference
Comparative Effectiveness of Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents on Prognosis in Non‐Dialysis Chronic Kidney Disease: A Propensity‐Matched Cohort Study
10.1080/0886022x.2025.2592442 · 2025 · External reference
